Ken Fisher
HUMA icon

Ken Fisher’s Humacyte HUMA Stock Holding History

Ken Fisher’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,400
Closed -$47.4K – 1066
2025
Q4 		$47.4K Buy
+49,400
New +$70K ﹤0.01% 1009

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Ken Fisher's HUMA Position: Q1 2026 in Review

Ken Fisher sold out of Humacyte (HUMA) in Q1 2026, closing a stake of 49,400 shares — an estimated $47.4K sold.

Ken Fisher first reported a position in HUMA in Q4 2025 and held it in 1 quarter. The position peaked at $47.4K in Q4 2025. 158 funds tracked by Wall St. Rank hold HUMA as of Q1 2026.

  • Ken Fisher reported no remaining Humacyte position as of Q1 2026 after selling out during the quarter.
  • Ken Fisher sold 49,400 Humacyte shares in Q1 2026, an estimated $47.4K.
  • Ken Fisher first reported a position in Humacyte in Q4 2025 and held it in 1 quarter.
  • Ken Fisher's Humacyte position peaked at $47.4K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Humacyte as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.